首页> 外文期刊>Neurosurgery >Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
【24h】

Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.

机译:磁共振成像和灌注加权成像在少突胶质细胞瘤术前分级中的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Oligodendroglial tumors form an uncommon, but distinct, subgroup of gliomas with longer survival, better treatment response, and characteristic genetic alterations. Noninvasive grading of oligodendroglial tumors using functional and metabolic magnetic resonance imaging may be helpful in guiding the treatment approach and predicting malignant transformation of these tumors. We used perfusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopic imaging (MRSI) to predict the oligodendroglioma grade. METHODS: Twenty-four patients with pathologically confirmed oligodendrogliomas underwent dynamic contrast-enhanced perfusion-weighted magnetic resonance imaging and/or proton MRSI before surgery. We assessed the ability of tumor contrast enhancement, normalized cerebral blood volume, normalized choline, and the presence of either lactate or lipid metabolites to correctly predict the World Health Organization tumor grade. The accuracy of tumor grading using each method was also compared. RESULTS: Tumor contrast enhancement (P = 0.069) and normalized cerebral blood volume (P = 0.181) were not significantly different between low and high-grade oligodendrogliomas. The MRSI measurement of normalized choline was significantly higher in high-grade (2.82 +/- 0.64) than in low-grade (1.62 +/- 0.46) oligodendrogliomas (P < 0.001), and the presence of lactate or lipid metabolites also correctly predicted high-grade tumors (P = 0.014). The maximum accuracy of contrast enhancement, normalized cerebral blood volume, normalized choline, and lactate or lipid metabolites in grading oligodendroglioma was 71, 83, 90, and 85%, respectively. CONCLUSION: MRSI measurements are more accurate than perfusion-weighted magnetic resonance imaging or conventional contrast enhancement in differentiating oligodendroglial tumor grade. In these inherently vascular tumors, metabolic measurements of mitosis and necrosis may be better than measures of neovascularity in presurgical grading.
机译:目的:少突胶质细胞瘤形成一种罕见,但截然不同的神经胶质瘤亚组,具有更长的生存期,更好的治疗反应和特征性的遗传改变。使用功能性和代谢性磁共振成像对少突胶质细胞瘤进行非侵入性分级可能有助于指导治疗方法和预测这些肿瘤的恶性转化。我们使用灌注加权磁共振成像和质子磁共振波谱成像(MRSI)来预测少突胶质细胞瘤的等级。方法:二十四例经病理证实的少突胶质细胞瘤患者在手术前接受了动态对比增强灌注加权磁共振成像和/或质子MRSI。我们评估了肿瘤造影剂增强,脑血量正常化,胆碱水平正常化以及乳酸或脂质代谢产物的存在的能力,以正确预测世界卫生组织的肿瘤等级。还比较了每种方法对肿瘤分级的准确性。结果:低度和高度少突胶质细胞瘤的肿瘤对比增强(P = 0.069)和正常脑血容量(P = 0.181)没有显着差异。高级别(2.82 +/- 0.64)的MRSI测量归一化胆碱显着高于低级别(1.62 +/- 0.46)少突胶质细胞瘤(P <0.001),并且乳酸或脂质代谢产物的存在也可以正确预测高度恶性肿瘤(P = 0.014)。分级少突神经胶质瘤的对比增强,脑血量标准化,胆碱标准化和乳酸或脂质代谢物的最大准确性分别为71%,83%,90%和85%。结论:在区分少突胶质肿瘤等级时,MRSI测量比灌注加权磁共振成像或常规对比增强检查更准确。在这些固有的血管肿瘤中,有丝分裂和坏死的代谢测量可能比术前分级中新血管形成的测量更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号